A large multi-center study published in Neurology found no significant differences in follow-up care needs between new neurology patients seen virtually and those seen in person during the COVID-19 ...
Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study. TACE with or without ...
A landmark multi-center study has found that GLP-1 receptor agonists significantly reduce atrial fibrillation-related events and mortality in patients with obesity and pre-existing AF, independent of ...
This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results